Brief: Aptose Biosciences Inc Presents Highlights From Corporate Update And Kol Event
02/06/2022 22:38
June 2 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES INC - PRESENTS HIGHLIGHTS FROM
CORPORATE
UPDATE AND KOL EVENT
* APTOSE BIOSCIENCES INC - NEW “G3” FORMULATION OF
LUXEPTINIB
DEMONSTRATES ENCOURAGING PK RESULTS
* APTOSE BIOSCIENCES INC - HM43239 DELIVERS NEW COMPLETE
REMISSION
AT 160MG DOSE IN AML WITH WILDTYPE FLT3
Further company coverage: APS.TO
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting